This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Feb. 26, 2014

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

Husband-wife team discover breakthrough using HIV drug
Philly.com
In the world's first clinical trial, a commonly used HIV drug may offer a light at the end of the tunnel to those suffering from one of the most common types of cancer in women. The women in the study were then treated with the antiviral HIV drug lopinavir. The researchers findings showed women with high-grade disease revert to a normal healthy cervix within a comparatively short period of time.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Registration open for 2014 conference
American Society for Cytotechnology
Registration is now open for the ASCT 2014 Annual Scientific Conference, April 25-27, at the Charleston Marriott in Charleston, S.C.

Click here for detailed information and registration.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


UPCOMING EVENTS

Date Event Location More information
Available now 2014 Revised Edition Introduction to the Cytopreparation Laboratory Online Course Your PC
More information


March 12
2 p.m. ET
A Practical Approach to On-Site Adequacy Assessment of Fine Needle Aspiration Biopsies Your PC
The webinar will feature Sara E. Monaco, M.D. associate professor, director of FNA Biopsy Service, Children's Hospital of Pittsburgh of UPMC, director, UPMC Cytopathology Fellowship Program, University of Pittsburgh Medical Center–Shadyside Hospital, Pittsburgh, Pa.
More information
Register
May 3-6 McGill Cytopathology Review Course Montreal, Quebec
Course Director: Dr. Manon Auger. For further information contact: cme@muhc.mcgill.ca, McGill University Health Centre Continuing Education Office, phone: (514) 934-8253, fax: (514) 934-1779
More information

Available for 6 months after subscribing

Quality Assessment Center (QAC) Document Control for Cytopathology Workbench

Your PC

Details

Available for 6 months after subscribing

Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench

Your PC

Details


INDUSTRY NEWS


HPV vaccine effective in some ways after only 2 doses
KYW-AM
It is too early to change recommendations but a Swedish study has found that it might take only two doses of the vaccine to offer protection against genital warts. The study looked at 1 million women, some of whom were never vaccinated and others who received one, two or all three doses of the vaccine.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword VACCINE


British researchers discover revolutionary therapy but are left fighting red tape
The Daily Telegraph via The Province
Ian Hampson is finding it hard to contain his excitement. A molecular virologist with a passionate interest in understanding the relationship between viruses and cancer, he thinks that he and his wife, Lynne, may — he stresses the word may — have found a revolutionary therapy for women with pre-cancerous cell changes in the cervix.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


More evidence that HPV vaccine might lower cervical cancer risk
HealthDay News
Just a few years after its introduction, a human papillomavirus (HPV) vaccine has reduced the risk of precancerous cervical lesions among young women in Denmark, a new study finds. While it's too soon to say for sure that HPV vaccination can lower cervical cancer risk, the Danish study offers more evidence that it might.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Gene test useful in head, neck cancer diagnosis
MedPage Today
A test to determine mutant-allele tumor heterogeneity accurately distinguished patients with high- and low-risk head and neck cancers, according to a study reported here. A high MATH score more than doubled the hazard ratio for survival among patients with various types of squamous carcinoma of the head and neck. The relationship between MATH score and outcome held up regardless of a patient's human papillomavirus status or other prognostic factors.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MORE NEWS


Next-generation gene sequencing could lead to more precise pathology lab tests
Dark Daily
Scientists are beginning to incorporate next-generation gene sequencing into a growing number of clinical trials. This is an important development because knowledge developed in clinical trials often forms the foundation for the evidence-based medicine guidelines issued following a successful clinical trial.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Can stem cells heal broken hearts?
CNN
The biggest ever stem cell trial involving heart attack patients has gotten underway in London. The study, which will involve 3,000 patients in 11 European countries, should show whether the treatment can cut death rates and repair damaged tissue after a heart attack.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cancer risk spurs concern over gyn procedure
MedPage Today
A common gynecologic procedure has come under scrutiny because of concern about unleashing cells from undiagnosed cancer. The Society of Gynecologic Oncology recently published a position statement advising physicians and patients to have a thorough discussion about the potential risks and benefits of morcellation before performing the procedure.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Feb. 12, 2014
Jan. 22, 2014
Jan. 8, 2014
Dec. 23, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063